Hyundai Pharmaceutical Co., Ltd. (KRX:004310)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,300.00
+250.00 (4.13%)
Jun 29, 2026, 3:30 PM KST
Market Cap174.37B +83.1%
Revenue (ttm)108.14B +5.8%
Net Income1.41B
EPS60.34
Shares Out 27.68M
PE Ratio104.41
Forward PEn/a
Dividend30.00 (0.50%)
Ex-Dividend DateMar 3, 2026
Volume1,010,757
Open5,850.00
Previous Close6,050.00
Day's Range5,850.00 - 6,760.00
52-Week Range3,380.00 - 15,960.00
Beta0.68
Analystsn/a
Price Targetn/a
Earnings Daten/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements